• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有不同物理化学性质和转运机制的化合物对大鼠肠道区域通透性的影响

Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms.

作者信息

Fagerholm U, Lindahl A, Lennernäs H

机构信息

Department of Pharmacy, University of Uppsala, Sweden.

出版信息

J Pharm Pharmacol. 1997 Jul;49(7):687-90. doi: 10.1111/j.2042-7158.1997.tb06093.x.

DOI:10.1111/j.2042-7158.1997.tb06093.x
PMID:9255712
Abstract

Because the absorption of orally administered drugs depends on intestinal permeability, we have investigated how absorptive capacity varies from the proximal to distal intestine in rats. The effective permeabilities of compounds with a range of physicochemical properties and different absorption mechanisms were estimated by use of a previously validated in-situ, single-pass perfusion model. The low colonic permeabilities of D-glucose and L-dopa indicate the absence or low capacity of the glucose- and amino-acid-transporters in this region. With the exception of the small and moderately lipophilic non-steroidal anti-inflammatory drug, naproxen, for which permeability was maintained throughout the intestine, the passive intestinal permeabilities for hydrophilic and lipophilic drugs were approximately twice as high in the jejunum and ileum as in the colon. These observations are in accord with those made in recent studies. However, the reasons for the high colonic permeability of non-steroidal anti-inflammatory drugs, and results obtained in previous animal experiments demonstrating that the colon is the region of the intestine with the highest absorptive capacity were not fully clarified. These data show that the permeability to hydrophilic and lipophilic drugs decreases along the intestine, whereas it is maintained throughout the intestine for the small and moderately lipophilic naproxen. Further investigations are required to clarify the interplay between membrane composition, fluidity and permeability under various conditions in different absorption models.

摘要

由于口服药物的吸收取决于肠道通透性,我们研究了大鼠从近端小肠到远端小肠的吸收能力如何变化。通过使用先前验证过的原位单通道灌注模型,估算了具有一系列物理化学性质和不同吸收机制的化合物的有效通透性。D-葡萄糖和L-多巴在结肠的低通透性表明该区域缺乏葡萄糖和氨基酸转运体或其转运能力较低。除了亲脂性适中的小分子非甾体抗炎药萘普生在整个肠道中都保持较高通透性外,亲水性和疏水性药物在空肠和回肠的被动肠道通透性大约是结肠的两倍。这些观察结果与最近的研究一致。然而,非甾体抗炎药结肠通透性高的原因以及先前动物实验表明结肠是肠道中吸收能力最高区域的结果尚未完全阐明。这些数据表明,亲水性和疏水性药物的通透性沿肠道降低,而亲脂性适中的小分子萘普生在整个肠道中通透性保持不变。需要进一步研究以阐明不同吸收模型中各种条件下膜组成、流动性和通透性之间的相互作用。

相似文献

1
Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms.具有不同物理化学性质和转运机制的化合物对大鼠肠道区域通透性的影响
J Pharm Pharmacol. 1997 Jul;49(7):687-90. doi: 10.1111/j.2042-7158.1997.tb06093.x.
2
Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.氟伐他汀在大鼠体内的肠道通透性的浓度及区域依赖性
J Pharm Pharmacol. 1998 Jul;50(7):737-44. doi: 10.1111/j.2042-7158.1998.tb07134.x.
3
Jejunal permeability and hepatic extraction of fluvastatin in humans.人空肠通透性及氟伐他汀的肝脏摄取
Clin Pharmacol Ther. 1996 Nov;60(5):493-503. doi: 10.1016/S0009-9236(96)90145-9.
4
Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.口服给药后药物的吸收部位:胃肠道各段药物膜通透性和管腔浓度的评估
Eur J Pharm Sci. 2006 Nov;29(3-4):240-50. doi: 10.1016/j.ejps.2006.06.004. Epub 2006 Jun 27.
5
Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2.大鼠中氟伐他汀的肠道局部吸收及胆汁排泄:多药耐药相关蛋白2(MRP2)可能参与其中
Mol Pharm. 2004 Sep-Oct;1(5):347-56. doi: 10.1021/mp0499297.
6
Absorption of D-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach.采用原位肠灌注法研究大鼠对D-葡萄糖的吸收:一种通透性指数方法。
Pharm Res. 1997 Nov;14(11):1563-7. doi: 10.1023/a:1012174217220.
7
Regional Intestinal Permeability in Rats: A Comparison of Methods.大鼠区域性肠道通透性:方法比较。
Mol Pharm. 2017 Dec 4;14(12):4252-4261. doi: 10.1021/acs.molpharmaceut.7b00279. Epub 2017 Oct 5.
8
Regional Intestinal Permeability of Three Model Drugs in Human.三种模型药物在人体中的区域肠道通透性
Mol Pharm. 2016 Sep 6;13(9):3013-21. doi: 10.1021/acs.molpharmaceut.6b00514. Epub 2016 Aug 18.
9
Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.口服给药后肠道各节段依赖性膜通透性:大鼠三重单通道肠道灌注(TSPIP)方法的评估
Eur J Pharm Sci. 2009 Feb 15;36(2-3):320-9. doi: 10.1016/j.ejps.2008.10.013. Epub 2008 Nov 5.
10
Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.多种外排泵参与秋水仙碱的跨上皮转运:p-糖蛋白和多药耐药相关蛋白 2 的联合作用导致整个小肠的肠道吸收减少。
Drug Metab Dispos. 2009 Oct;37(10):2028-36. doi: 10.1124/dmd.109.028282. Epub 2009 Jul 9.

引用本文的文献

1
Influence of osmolality on gastrointestinal fluid volume and drug absorption: potential impact on oral salt supplementation.渗透压对胃肠液体积和药物吸收的影响:对口服补充盐分的潜在影响。
J Pharm Health Care Sci. 2021 Sep 1;7(1):29. doi: 10.1186/s40780-021-00212-z.
2
Oleacein Intestinal Permeation and Metabolism in Rats Using an In Situ Perfusion Technique.采用原位灌注技术研究大鼠中油橄榄苦素的肠道渗透与代谢
Pharmaceutics. 2021 May 14;13(5):719. doi: 10.3390/pharmaceutics13050719.
3
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat.
大鼠肠道局部药物渗透性及渗透促进剂的作用
Pharmaceutics. 2020 Mar 8;12(3):242. doi: 10.3390/pharmaceutics12030242.
4
Different modulation of on the absorption profiling of triptolide and tripterine from in rat intestine.不同因素对雷公藤甲素和雷公藤红素在大鼠肠道中吸收曲线的影响。 (注:原文句子不完整,存在信息缺失,此翻译是根据现有内容尽量完善后的表述)
Chin Med. 2018 Jan 8;13:1. doi: 10.1186/s13020-017-0157-6. eCollection 2018.
5
Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release Formulations.生物制药评估和口服缓释制剂的 CMC 方面。
AAPS J. 2017 Sep;19(5):1348-1358. doi: 10.1208/s12248-017-0112-6. Epub 2017 Jul 5.
6
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.左旋多巴-卡比多巴肠凝胶的药代动力学:变异性低于口服左旋多巴-卡比多巴。
J Parkinsons Dis. 2017;7(2):275-278. doi: 10.3233/JPD-161042.
7
Dynamic analysis of GI absorption and hepatic distribution processes of telmisartan in rats using positron emission tomography.应用正电子发射断层扫描技术对替米沙坦在大鼠体内的胃肠道吸收和肝脏分布过程进行动态分析。
Pharm Res. 2012 Sep;29(9):2419-31. doi: 10.1007/s11095-012-0768-7. Epub 2012 May 23.
8
Biomagnetic methods: technologies applied to pharmaceutical research.生物磁学方法:应用于药物研究的技术。
Pharm Res. 2011 Mar;28(3):438-55. doi: 10.1007/s11095-010-0285-5. Epub 2010 Oct 15.
9
Application of method suitability for drug permeability classification.药物渗透性分类方法适用性的应用。
AAPS J. 2010 Dec;12(4):670-8. doi: 10.1208/s12248-010-9227-8. Epub 2010 Sep 2.
10
Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide.有机阴离子转运多肽介导的 HMG-CoA 还原酶抑制剂普伐他汀的肠道吸收。
Pharm Res. 2010 Oct;27(10):2141-9. doi: 10.1007/s11095-010-0216-5. Epub 2010 Aug 5.